Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-05-16 to 2024-06-07
Current total value of award: $102733.8
Description: 4564641173!XOLAIR 300 MG/2 ML AUTOINJECT 2ML